PATENT CLAIM ANALYSIS

Application Number: 16001247
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "221000"]

Abstract:
The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

Claim (Index 18):
The method of  claim 12 , wherein administering the compound allows for administering of the additional anti-RSV agent at a lower dose or frequency as compared to the dose or frequency required to achieve similar results in prophylactically treating an RSV infection in an individual in need thereof when the additional anti-RSV agent is administered alone.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 94.0
- Lexical Diversity: 1.6
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15216119', '15863216', '15914016', '11503502', '12108624']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8097934255654456
- 35 USC 102 Novelty (BERT): 0.534578415734572
- Combined Prediction Score: 0.7822719245823583
- Mean Citation Score: 336.74302
- Max Citation Score: 367.8282
- Similarity Product: 274.1889446728706

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test